Cilostazol-combo antiplatelet therapy reduced risk for recurrent stroke

(American Heart Association) The long-term combination of cilostazol with aspirin or clopidogrel resulted in fewer recurrent strokes than with aspirin or clopidogrel alone in high-risk patients.